Evidence map›Paper›PMID 30100693›Full record

ArticleMedicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents2018

Synthesis and biological investigations of 3β-aminotropane arylamide derivatives with atypical antipsychotic profile.

Jacek Stefanowicz, Tomasz Słowiński, Martyna Z Wróbel, Grzegorz Ślifirski, Maciej Dawidowski, Zdzisława Stefanowicz, Magdalena Jastrzębska-Więsek, Anna Partyka, Anna Wesołowska, Jadwiga Turło

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Tropanes in natural products, syntheses, and drugs: some insights from the new millennium.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jacek Stefanowicz1Department of Drug Technology and Pharmaceutical Biotechnology, Faculty of Pharmacy, Medical University of Warsaw, 1 Banacha Street, 02-097 Warsaw, Poland.
Tomasz Słowiński1Department of Drug Technology and Pharmaceutical Biotechnology, Faculty of Pharmacy, Medical University of Warsaw, 1 Banacha Street, 02-097 Warsaw, Poland.
Martyna Z Wróbel1Department of Drug Technology and Pharmaceutical Biotechnology, Faculty of Pharmacy, Medical University of Warsaw, 1 Banacha Street, 02-097 Warsaw, Poland.
Grzegorz Ślifirski1Department of Drug Technology and Pharmaceutical Biotechnology, Faculty of Pharmacy, Medical University of Warsaw, 1 Banacha Street, 02-097 Warsaw, Poland.
Maciej Dawidowski1Department of Drug Technology and Pharmaceutical Biotechnology, Faculty of Pharmacy, Medical University of Warsaw, 1 Banacha Street, 02-097 Warsaw, Poland.
Zdzisława Stefanowicz2Department of Inorganic and Analytical Chemistry, Faculty of Pharmacy, Medical University of Warsaw, 1 Banacha Street, 02-097 Warsaw, Poland.
Magdalena Jastrzębska-Więsek3Department of Clinical Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, 30-688 Cracow, Poland.
Anna Partyka3Department of Clinical Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, 30-688 Cracow, Poland.
Anna Wesołowska3Department of Clinical Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, 30-688 Cracow, Poland.
Jadwiga Turło1Department of Drug Technology and Pharmaceutical Biotechnology, Faculty of Pharmacy, Medical University of Warsaw, 1 Banacha Street, 02-097 Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work is a continuation of our previous research, concentrating this time on lead structure modification to increase the 5-HT

Indexed as

3β-aminotropane derivatives5-HT1A, 5-HT2A, D2Atypical antipsychoticsDopamine receptor ligands

Identifiers

PMID30100693
PMCPMC6061170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.